Literature DB >> 17061738

Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.

Ifeoma I Ulasi1, Ejikeme B Arodiwe, Chinwuba K Ijoma.   

Abstract

OBJECTIVE: Chronic kidney disease (CKD) is a major cause of cardiovascular morbidity and mortality all over the world. The combined effect of volume and pressure overload seen in patients with CKD is the primary cause of left ventricular hypertrophy (LVH). Though it accounts for a significant proportion of patients dying in hospitals in Nigeria, information on CKD in African Blacks is lacking. This study evaluates the prevalence of LVH and factors affecting it in pre-dialysis patients by using echocardiography. DESIGN, SETTING AND PATIENTS: One hundred consecutive patients with CKD who were attending the medical outpatient and renal clinics of University of Nigeria Teaching Hospital, Enugu, who satisfied the inclusion criteria were screened for the study. Eighty-eight patients completed the study. Forty-five age- and sex-matched subjects were selected as controls. Clinical and laboratory parameters and echocardiographic indices were measured.
RESULTS: Left ventricular hypertrophy (LVH), defined in absolute terms as left ventricular mass index >134 g/m2 in men and >110 g/m2 in women was present in 95.5% of patients and 6.7% of controls. The most prevalent type of LVH was eccentric hypertrophy, which was found in 54.6%, while concentric was seen in 40.9%. Hypertension was present in 85.2% of the patients. The predominant causes of CKD were chronic glomerulonephritis (43.2%), hypertension (25%), and diabetes mellitus (14.8%). All the patients studied had advanced CKD, either stage 4 or 5 of the Kidney Disease Outcome Quality Initiative classification of CKD. Stepwise method of multiple linear regressions identified mean arterial pressure (32%), hemoglobin concentration (22%), male sex (17%), and creatinine clearance (24%) as predictors of LVH in CKD.
CONCLUSION: This study showed a strong association between CKD and LVH in patients in developing countries at the time of first evaluation by a nephrologist. It demonstrated a high prevalence of LVH in patients at first evaluation. The patients were often anemic and had severe hypertension even at first presentation. Early detection and treatment of causes of CKD should be pursued aggressively at the primary prevention level, as has been advocated by the International Society of Nephrology to reduce the effects of CKD and its attendant complications in the society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061738

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  12 in total

1.  Comparison of Left Ventricular Hypertrophy, Fibrosis and Dysfunction According to Various Disease Mechanisms such as Hypertension, Diabetes Mellitus and Chronic Renal Failure.

Authors:  Yoon-Seok Koh; Hae-Ok Jung; Mahn-Won Park; Joo-Yeoul Baek; Sung-Gyu Yoon; Pum-Joon Kim; Sang-Hyun Ihm; Kiyuk Chang; Yong-Seog Oh; Ho-Joong Youn; Sang Hong Baek; Wook-Sung Chung; Ki-Bae Seung; Jae-Hyung Kim
Journal:  J Cardiovasc Ultrasound       Date:  2009-12-31

2.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction.

Authors:  Kirandeep K Khangura; Alfonso Eirin; Garvan C Kane; Sanjay Misra; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2013-10-25       Impact factor: 2.689

3.  Arterial stiffness in black African ancestry patients with chronic kidney disease living in Cameroon.

Authors:  Daniel Lemogoum; Marie Patrice Halle; Ruth Dione Mboule; Philippe Van de Borne; Elysée Claude Bika Lele; Felicité Kamdem; Marie Solange Doualla; Henry Luma; Michel P Hermans; Luc Van Bortel
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

4.  Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study.

Authors:  M P Bayauli; F B Lepira; P K Kayembe; J R M'buyamba-Kabangu
Journal:  Cardiovasc J Afr       Date:  2012-03       Impact factor: 1.167

5.  Assessment of some cardiovascular risk factors in predialysis chronic kidney disease patients in Southern Nigeria.

Authors:  Oluseyi A Adejumo; Enajite I Okaka; George Madumezia; Chimezie G Okwuonu; Louis I Ojogwu
Journal:  Niger Med J       Date:  2015 Nov-Dec

6.  Cardiovascular risk factors among patients with chronic kidney disease attending a tertiary hospital in Uganda.

Authors:  Christopher Babua; Robert Kalyesubula; Emmy Okello; Barbara Kakande; Elias Sebatta; Michael Mungoma; Charles Kiiza Mondo
Journal:  Cardiovasc J Afr       Date:  2015 Jul-Aug       Impact factor: 1.167

7.  Chronic kidney disease in Nigeria: Late presentation is still the norm.

Authors:  Oluseyi A Adejumo; Ayodeji A Akinbodewa; Enajite I Okaka; Oladimeji E Alli; Ifedayo F Ibukun
Journal:  Niger Med J       Date:  2016 May-Jun

8.  A predominance of hypertensive heart disease among patients with cardiac disease in Buea, a semi-urban setting, South West Region of Cameroon.

Authors:  Clovis Nkoke; Christelle Makoge; Anastase Dzudie; Liliane Kuate Mfeukeu; Engelbert Bain Luchuo; Alain Menanga; Samuel Kingue
Journal:  BMC Res Notes       Date:  2017-12-04

9.  Spectrum of heart diseases in a new cardiac service in Nigeria: an echocardiographic study of 1441 subjects in Abeokuta.

Authors:  Okechukwu S Ogah; Gail D Adegbite; Rufus O Akinyemi; Julius O Adesina; Albert A Alabi; Oscar I Udofia; Roseline F Ogundipe; Julius K L Osinfade
Journal:  BMC Res Notes       Date:  2008-10-28

10.  Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study.

Authors:  Christopher Babua; Robert Kalyesubula; Emmy Okello; Barbara Kakande; Erias Sebatta; Michael Mungoma; Charles Mondo
Journal:  BMC Nephrol       Date:  2015-08-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.